Ihuman Historical Balance Sheet
| IH Stock | USD 1.52 0.03 1.94% |
Trend analysis of Ihuman Inc balance sheet accounts such as Total Current Liabilities of 410.5 M provides information on Ihuman's total assets, liabilities, and equity, which is the actual value of Ihuman Inc to its prevalent stockholders. By breaking down trends over time using Ihuman balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Ihuman Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ihuman Inc is a good buy for the upcoming year.
Ihuman Inventory |
|
Ihuman |
About Ihuman Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Ihuman Inc at a specified time, usually calculated after every quarter, six months, or one year. Ihuman Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ihuman and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ihuman currently owns. An asset can also be divided into two categories, current and non-current.
Ihuman Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Ihuman assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ihuman Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Ihuman balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ihuman Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Ihuman's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ihuman Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Ihuman's Accounts Payable is increasing as compared to previous years. The Ihuman's current Inventory is estimated to increase to about 17.4 M, while Total Assets are projected to decrease to under 945.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 104.7M | 118.8M | 438.0M | 459.9M | Total Assets | 1.1B | 1.3B | 1.5B | 945.7M |
Ihuman balance sheet Correlations
Click cells to compare fundamentals
Ihuman Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ihuman balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
| Other Current Liab | 880K | 90.1M | 104.7M | 118.8M | 438.0M | 459.9M | |
| Total Current Liabilities | 182.8M | 399.2M | 482.9M | 561.1M | 490.8M | 410.5M | |
| Total Stockholder Equity | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
| Property Plant And Equipment Net | 2.5M | 12.9M | 50.5M | 22.0M | 9.8M | 18.0M | |
| Current Deferred Revenue | 71.8M | 268.6M | 303.0M | 379.1M | 318.6M | 251.0M | |
| Net Debt | (104.9M) | (855.1M) | (821.1M) | (1.0B) | (1.2B) | (1.1B) | |
| Retained Earnings | (348.5M) | (386.0M) | (423.0M) | (321.2M) | (140.5M) | (147.5M) | |
| Accounts Payable | 10.3M | 21.6M | 30.5M | 24.2M | 22.1M | 22.3M | |
| Cash | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
| Non Current Assets Total | 5.3M | 25.5M | 85.6M | 79.6M | 68.1M | 48.6M | |
| Non Currrent Assets Other | 2.7M | 784K | 7.8M | 6.4M | 8.7M | 4.9M | |
| Other Assets | 2.7M | 784K | 7.8M | 6.4M | 7.4M | 4.0M | |
| Cash And Short Term Investments | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
| Net Receivables | 21.0M | 78.3M | 59.0M | 81.9M | 62.6M | 58.0M | |
| Liabilities And Stockholders Equity | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
| Non Current Liabilities Total | 82.1M | 5.1M | 9.6M | 2.9M | 1.9M | 1.8M | |
| Capital Surpluse | 213.1M | 1.1B | 1.1B | 1.1B | 1.2B | 751.9M | |
| Inventory | 20.7M | 16.9M | 28.1M | 19.1M | 16.5M | 17.4M | |
| Other Current Assets | 574K | 64.6M | 72.9M | 102.8M | 89.5M | 60.9M | |
| Other Stockholder Equity | 333.9M | 1.1B | 1.1B | 1.1B | 1.1B | 844.0M | |
| Total Liab | 182.8M | 404.3M | 492.5M | 563.9M | 492.7M | 414.1M | |
| Net Invested Capital | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
| Total Current Assets | 163.1M | 1.0B | 1.0B | 1.3B | 1.4B | 897.1M | |
| Accumulated Other Comprehensive Income | 0.0 | (21.9M) | (34.7M) | 18.5M | 26.1M | 27.4M | |
| Cash And Equivalents | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 633.2M | |
| Net Working Capital | (19.7M) | 622.2M | 532.3M | 692.7M | 891.7M | 486.6M | |
| Short Term Debt | 99.8M | 1.5M | 24.7M | 6.1M | 1.9M | 1.8M | |
| Intangible Assets | 103K | 11.8M | 27.3M | 24.9M | 23.2M | 16.0M | |
| Property Plant Equipment | 2.5M | 12.9M | 50.5M | 22.0M | 25.3M | 19.5M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.